TY  - CONF

T1  - The utility of minimal residual disease (MRD) assessment in post-first relapse re-induction: results from the BSBMT/UKMF Myeloma X (intensive) Trial

JO  - BRITISH JOURNAL OF HAEMATOLOGY

PY  - 2014/05/01

AU  - Owen RG

AU  - DeTute DM

AU  - Ashcroft AJ

AU  - Cairns DA

AU  - Fletcher M

AU  - Williams C

AU  - Cavenagh JD

AU  - Snowden JA

AU  - Rawstron AC

AU  - Parrish C

AU  - Morris TC et al

ED  - 

VL  - 165

SP  - 65

EP  - 66

Y2  - 2024/12/22

ER  -